You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 7, April 13, 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Diagnosis
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Diagnostic Utility of the Polymerase Chain Reaction in 2 Cases of Suspected Whipple Disease

Kjetil Taskén, MD, PhD; Tom Schulz, MD, PhD; Kjell Elgjo, MD, PhD; Kari Skullerud, MD, PhD; David Relman, MD; Oddbjørn Brubakk, MD, PhD

Arch Intern Med. 1998;158:801-803.

We describe 2 patients with a diagnosis of Whipple disease in whom the usual antibiotic therapy failed. A polymerase chain reaction–based test was used to identify the recently described Whipple bacillus, Tropheryma whippelii. In one case, the diagnosis was confirmed, whereas in the second case, which had been histologically diagnosed as Whipple disease of the brain, the process was identified as a monocyte-derived histiocytosis. In conclusion, Whipple disease can be distinguished from other diseases with similar histological features with the use of a polymerase chain reaction–based test.


From the Department of Medicine, Østfold Sentralsykehus, Sarpsborg, Norway (Drs Taskén and Brubakk); the Department of Medicine, Aust-Agder Sentralsykehus, Arendal, Norway (Dr Schulz); the Department of Pathology, The National Hospital (Drs Elgjo and Skullerud), and the Institute of Medical Biochemistry, University of Oslo (Dr Taskén), Oslo, Norway; the Veterans Affairs Palo Alto Health Care System, Palo Alto, Calif (Dr Relman); and the Departments of Medicine and Microbiology and Immunology, Stanford University School of Medicine, Stanford, Calif (Dr Relman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Whipple's Disease and ""Tropheryma whippelii""
Dutly and Altwegg
Clin. Microbiol. Rev. 2001;14:561-583.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.